Takeda’s narcolepsy nod opens orexin doors

Orzeyful is the first orexin agonist cleared by the FDA, and is the first narcolepsy therapy that addresses the full host of disease symptoms. It is "likely to reshape the treatment paradigm” for the condition, Jefferies told investors.